25 XP   0   0   10

Arcoma AB
Buy, Hold or Sell?

Let's analyse Arcoma together

PenkeI guess you are interested in Arcoma AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Arcoma AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Arcoma AB

I send you an email if I find something interesting about Arcoma AB.

Quick analysis of Arcoma (30 sec.)










What can you expect buying and holding a share of Arcoma? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr3.65
Expected worth in 1 year
kr3.83
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
kr0.17
Return On Investment
1.2%

For what price can you sell your share?

Current Price per Share
kr14.00
Expected price per share
kr12.45 - kr14.15
How sure are you?
50%

1. Valuation of Arcoma (5 min.)




Live pricePrice per Share (EOD)

kr14.00

Intrinsic Value Per Share

kr0.11 - kr20.51

Total Value Per Share

kr3.77 - kr24.16

2. Growth of Arcoma (5 min.)




Is Arcoma growing?

Current yearPrevious yearGrowGrow %
How rich?$4.4m$4m$137.1k3.3%

How much money is Arcoma making?

Current yearPrevious yearGrowGrow %
Making money$48.9k$28.7k$20.2k41.4%
Net Profit Margin1.0%0.7%--

How much money comes from the company's main activities?

3. Financial Health of Arcoma (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#259 / 334

Most Revenue
#220 / 334

Most Profit
#113 / 334

Most Efficient
#111 / 334

What can you expect buying and holding a share of Arcoma? (5 min.)

Welcome investor! Arcoma's management wants to use your money to grow the business. In return you get a share of Arcoma.

What can you expect buying and holding a share of Arcoma?

First you should know what it really means to hold a share of Arcoma. And how you can make/lose money.

Speculation

The Price per Share of Arcoma is kr14.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Arcoma.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Arcoma, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr3.65. Based on the TTM, the Book Value Change Per Share is kr0.04 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.77 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Arcoma.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.020.1%0.000.0%0.010.1%0.000.0%0.000.0%
Usd Book Value Change Per Share0.020.1%0.000.0%0.070.5%0.000.0%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.020.1%0.000.0%0.070.5%0.000.0%0.010.1%
Usd Price Per Share0.73-0.77-0.73-1.37-1.00-
Price to Earnings Ratio10.51-21.10-38.98-29.74-35.64-
Price-to-Total Gains Ratio35.49-750.18-87.99-247.84-98.69-
Price to Book Ratio2.18-2.46-2.39-5.58-3.91-
Price-to-Total Gains Ratio35.49-750.18-87.99-247.84-98.69-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.2908
Number of shares774
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (774 shares)3.102.47
Gains per Year (774 shares)12.399.88
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101220100
20251402010
30372603020
40503804030
50625004940
60746205950
70877406960
80998607970
901119808980
10012411009990

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%9.03.00.075.0%16.04.00.080.0%24.016.00.060.0%24.018.00.057.1%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%16.04.00.080.0%24.015.01.060.0%25.015.02.059.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.042.00.0%
Total Gains per Share3.01.00.075.0%9.03.00.075.0%16.04.00.080.0%24.015.01.060.0%25.015.02.059.5%

Fundamentals of Arcoma

About Arcoma AB

Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray systems for radiographic applications, as well as for use in general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. The company sells its products through OEM partners. Arcoma AB was incorporated in 1990 and is based in Växjö, Sweden.

Fundamental data was last updated by Penke on 2024-04-19 06:52:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Arcoma AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Arcoma earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Arcoma to the Medical Devices industry mean.
  • A Net Profit Margin of 4.9% means that kr0.05 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Arcoma AB:

  • The MRQ is 4.9%. The company is making a profit. +1
  • The TTM is 1.0%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.9%TTM1.0%+3.9%
TTM1.0%YOY0.7%+0.3%
TTM1.0%5Y-0.4%+1.4%
5Y-0.4%10Y-3.6%+3.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9%-11.2%+16.1%
TTM1.0%-17.5%+18.5%
YOY0.7%-13.2%+13.9%
5Y-0.4%-19.6%+19.2%
10Y-3.6%-25.0%+21.4%
1.1.2. Return on Assets

Shows how efficient Arcoma is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Arcoma to the Medical Devices industry mean.
  • 3.1% Return on Assets means that Arcoma generated kr0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Arcoma AB:

  • The MRQ is 3.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.7%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.1%TTM0.7%+2.4%
TTM0.7%YOY0.3%+0.4%
TTM0.7%5Y0.2%+0.5%
5Y0.2%10Y-0.9%+1.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1%-3.9%+7.0%
TTM0.7%-4.1%+4.8%
YOY0.3%-4.1%+4.4%
5Y0.2%-3.7%+3.9%
10Y-0.9%-4.4%+3.5%
1.1.3. Return on Equity

Shows how efficient Arcoma is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Arcoma to the Medical Devices industry mean.
  • 5.2% Return on Equity means Arcoma generated kr0.05 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Arcoma AB:

  • The MRQ is 5.2%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 1.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ5.2%TTM1.0%+4.2%
TTM1.0%YOY0.7%+0.3%
TTM1.0%5Y0.4%+0.6%
5Y0.4%10Y-1.8%+2.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.2%-3.9%+9.1%
TTM1.0%-4.7%+5.7%
YOY0.7%-4.8%+5.5%
5Y0.4%-5.6%+6.0%
10Y-1.8%-6.4%+4.6%

1.2. Operating Efficiency of Arcoma AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Arcoma is operating .

  • Measures how much profit Arcoma makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Arcoma to the Medical Devices industry mean.
  • An Operating Margin of 9.0% means the company generated kr0.09  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Arcoma AB:

  • The MRQ is 9.0%. The company is operating less efficient.
  • The TTM is 3.2%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ9.0%TTM3.2%+5.9%
TTM3.2%YOY2.3%+0.9%
TTM3.2%5Y0.7%+2.5%
5Y0.7%10Y-3.2%+3.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ9.0%-26.7%+35.7%
TTM3.2%-14.7%+17.9%
YOY2.3%-13.1%+15.4%
5Y0.7%-18.5%+19.2%
10Y-3.2%-24.8%+21.6%
1.2.2. Operating Ratio

Measures how efficient Arcoma is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.91 means that the operating costs are kr0.91 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Arcoma AB:

  • The MRQ is 0.910. The company is less efficient in keeping operating costs low.
  • The TTM is 0.969. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.910TTM0.969-0.060
TTM0.969YOY0.969+0.000
TTM0.9695Y0.988-0.019
5Y0.98810Y1.028-0.040
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9101.429-0.519
TTM0.9691.425-0.456
YOY0.9691.389-0.420
5Y0.9881.419-0.431
10Y1.0281.376-0.348

1.3. Liquidity of Arcoma AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Arcoma is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.75 means the company has kr1.75 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Arcoma AB:

  • The MRQ is 1.752. The company is able to pay all its short-term debts. +1
  • The TTM is 1.440. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.752TTM1.440+0.312
TTM1.440YOY1.384+0.056
TTM1.4405Y1.4400.000
5Y1.44010Y1.312+0.128
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7522.685-0.933
TTM1.4402.709-1.269
YOY1.3843.407-2.023
5Y1.4403.621-2.181
10Y1.3123.499-2.187
1.3.2. Quick Ratio

Measures if Arcoma is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Arcoma to the Medical Devices industry mean.
  • A Quick Ratio of 0.80 means the company can pay off kr0.80 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Arcoma AB:

  • The MRQ is 0.800. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.695. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.800TTM0.695+0.104
TTM0.695YOY0.743-0.047
TTM0.6955Y0.632+0.063
5Y0.63210Y0.391+0.242
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8001.494-0.694
TTM0.6951.637-0.942
YOY0.7432.107-1.364
5Y0.6322.308-1.676
10Y0.3912.419-2.028

1.4. Solvency of Arcoma AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Arcoma assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Arcoma to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.41 means that Arcoma assets are financed with 40.6% credit (debt) and the remaining percentage (100% - 40.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Arcoma AB:

  • The MRQ is 0.406. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.494. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.406TTM0.494-0.088
TTM0.494YOY0.513-0.019
TTM0.4945Y0.475+0.019
5Y0.47510Y0.503-0.028
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4060.406+0.000
TTM0.4940.398+0.096
YOY0.5130.347+0.166
5Y0.4750.442+0.033
10Y0.5030.457+0.046
1.4.2. Debt to Equity Ratio

Measures if Arcoma is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Arcoma to the Medical Devices industry mean.
  • A Debt to Equity ratio of 68.4% means that company has kr0.68 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Arcoma AB:

  • The MRQ is 0.684. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.996. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.684TTM0.996-0.311
TTM0.996YOY1.060-0.064
TTM0.9965Y0.917+0.079
5Y0.91710Y1.297-0.381
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6840.596+0.088
TTM0.9960.596+0.400
YOY1.0600.495+0.565
5Y0.9170.631+0.286
10Y1.2970.699+0.598

2. Market Valuation of Arcoma AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Arcoma generates.

  • Above 15 is considered overpriced but always compare Arcoma to the Medical Devices industry mean.
  • A PE ratio of 10.51 means the investor is paying kr10.51 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Arcoma AB:

  • The EOD is 18.515. Based on the earnings, the company is fair priced.
  • The MRQ is 10.514. Based on the earnings, the company is underpriced. +1
  • The TTM is 21.103. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD18.515MRQ10.514+8.001
MRQ10.514TTM21.103-10.589
TTM21.103YOY38.975-17.873
TTM21.1035Y29.742-8.640
5Y29.74210Y35.636-5.894
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD18.515-0.968+19.483
MRQ10.514-1.633+12.147
TTM21.103-2.187+23.290
YOY38.975-2.814+41.789
5Y29.742-2.446+32.188
10Y35.636-2.020+37.656
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Arcoma AB:

  • The EOD is 3.283. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 1.864. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -0.159. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD3.283MRQ1.864+1.419
MRQ1.864TTM-0.159+2.023
TTM-0.159YOY-4.293+4.135
TTM-0.1595Y1.087-1.245
5Y1.08710Y0.973+0.113
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD3.283-1.224+4.507
MRQ1.864-2.109+3.973
TTM-0.159-3.213+3.054
YOY-4.293-6.112+1.819
5Y1.087-4.928+6.015
10Y0.973-5.626+6.599
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Arcoma is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 2.18 means the investor is paying kr2.18 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Arcoma AB:

  • The EOD is 3.833. Based on the equity, the company is fair priced.
  • The MRQ is 2.176. Based on the equity, the company is underpriced. +1
  • The TTM is 2.458. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.833MRQ2.176+1.656
MRQ2.176TTM2.458-0.282
TTM2.458YOY2.388+0.071
TTM2.4585Y5.578-3.120
5Y5.57810Y3.914+1.664
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD3.8332.055+1.778
MRQ2.1762.372-0.196
TTM2.4582.470-0.012
YOY2.3883.081-0.693
5Y5.5783.918+1.660
10Y3.9144.381-0.467
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Arcoma AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2240.043+416%0.767-71%0.035+547%0.088+155%
Book Value Per Share--3.6533.426+7%3.332+10%3.389+8%3.023+21%
Current Ratio--1.7521.440+22%1.384+27%1.440+22%1.312+34%
Debt To Asset Ratio--0.4060.494-18%0.513-21%0.475-14%0.503-19%
Debt To Equity Ratio--0.6840.996-31%1.060-35%0.917-25%1.297-47%
Dividend Per Share----0%-0%-0%-0%
Eps--0.1890.048+296%0.086+121%0.053+258%-0.028+115%
Free Cash Flow Per Share--1.0660.313+241%-0.083+108%-0.014+101%-0.076+107%
Free Cash Flow To Equity Per Share--0.092-0.087+194%0.100-8%-0.009+110%-0.028+130%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--20.511--------
Intrinsic Value_10Y_min--0.114--------
Intrinsic Value_1Y_max--0.326--------
Intrinsic Value_1Y_min---0.252--------
Intrinsic Value_3Y_max--2.297--------
Intrinsic Value_3Y_min---0.534--------
Intrinsic Value_5Y_max--5.858--------
Intrinsic Value_5Y_min---0.568--------
Market Cap184598400.000+43%105898452.000111102007.000-5%104627736.000+1%257113464.600-59%173321217.984-39%
Net Profit Margin--0.0490.010+379%0.007+586%-0.004+108%-0.036+174%
Operating Margin--0.0900.032+186%0.023+294%0.007+1245%-0.032+136%
Operating Ratio--0.9100.969-6%0.969-6%0.988-8%1.028-12%
Pb Ratio3.833+43%2.1762.458-11%2.388-9%5.578-61%3.914-44%
Pe Ratio18.515+43%10.51421.103-50%38.975-73%29.742-65%35.636-70%
Price Per Share14.000+43%7.9508.388-5%7.935+0%14.837-46%10.813-26%
Price To Free Cash Flow Ratio3.283+43%1.864-0.159+109%-4.293+330%1.087+72%0.973+92%
Price To Total Gains Ratio62.496+43%35.489750.183-95%87.993-60%247.842-86%98.687-64%
Quick Ratio--0.8000.695+15%0.743+8%0.632+26%0.391+105%
Return On Assets--0.0310.007+366%0.003+934%0.002+1469%-0.009+128%
Return On Equity--0.0520.010+408%0.007+653%0.004+1217%-0.018+134%
Total Gains Per Share--0.2240.043+416%0.767-71%0.035+547%0.088+155%
Usd Book Value--4486175.4004187562.650+7%4050392.100+11%4302536.050+4%3790799.515+18%
Usd Book Value Change Per Share--0.0210.004+416%0.071-71%0.003+547%0.008+155%
Usd Book Value Per Share--0.3370.316+7%0.307+10%0.312+8%0.279+21%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0170.004+296%0.008+121%0.005+258%-0.003+115%
Usd Free Cash Flow--1309240.000383183.200+242%-100774.600+108%5638.030+23122%-87269.605+107%
Usd Free Cash Flow Per Share--0.0980.029+241%-0.008+108%-0.001+101%-0.007+107%
Usd Free Cash Flow To Equity Per Share--0.009-0.008+194%0.009-8%-0.001+110%-0.003+130%
Usd Market Cap17019972.480+43%9763837.27410243605.045-5%9646677.259+1%23705861.436-59%15980216.298-39%
Usd Price Per Share1.291+43%0.7330.773-5%0.732+0%1.368-46%0.997-26%
Usd Profit--232159.60048981.250+374%28720.300+708%17859.140+1200%-56855.130+124%
Usd Revenue--4732257.2003757472.700+26%2890193.400+64%3027105.790+56%2819646.570+68%
Usd Total Gains Per Share--0.0210.004+416%0.071-71%0.003+547%0.008+155%
 EOD+4 -4MRQTTM+28 -5YOY+24 -95Y+28 -510Y+28 -5

3.2. Fundamental Score

Let's check the fundamental score of Arcoma AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1518.515
Price to Book Ratio (EOD)Between0-13.833
Net Profit Margin (MRQ)Greater than00.049
Operating Margin (MRQ)Greater than00.090
Quick Ratio (MRQ)Greater than10.800
Current Ratio (MRQ)Greater than11.752
Debt to Asset Ratio (MRQ)Less than10.406
Debt to Equity Ratio (MRQ)Less than10.684
Return on Equity (MRQ)Greater than0.150.052
Return on Assets (MRQ)Greater than0.050.031
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Arcoma AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5071.375
Ma 20Greater thanMa 5012.608
Ma 50Greater thanMa 10012.274
Ma 100Greater thanMa 20010.762
OpenGreater thanClose13.700
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Debt  15,432-14,0551,37711,27712,65447413,128-14,256-1,128
Total Operating Expenses  12,5061,62814,134-10014,034-2,39511,639-12,668-1,029



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets81,962
Total Liabilities33,305
Total Stockholder Equity48,657
 As reported
Total Liabilities 33,305
Total Stockholder Equity+ 48,657
Total Assets = 81,962

Assets

Total Assets81,962
Total Current Assets54,657
Long-term Assets27,305
Total Current Assets
Cash And Cash Equivalents 5,001
Net Receivables 19,953
Inventory 28,027
Other Current Assets 1,676
Total Current Assets  (as reported)54,657
Total Current Assets  (calculated)54,657
+/-0
Long-term Assets
Property Plant Equipment 1,390
Goodwill 670
Intangible Assets 18,724
Long-term Assets Other 2
Long-term Assets  (as reported)27,305
Long-term Assets  (calculated)20,786
+/- 6,519

Liabilities & Shareholders' Equity

Total Current Liabilities31,204
Long-term Liabilities2,101
Total Stockholder Equity48,657
Total Current Liabilities
Short-term Debt 1,946
Short Long Term Debt 1,946
Accounts payable 21,436
Other Current Liabilities 7,184
Total Current Liabilities  (as reported)31,204
Total Current Liabilities  (calculated)32,512
+/- 1,308
Long-term Liabilities
Long term Debt 1,927
Long-term Liabilities Other 1
Long-term Liabilities  (as reported)2,101
Long-term Liabilities  (calculated)1,928
+/- 173
Total Stockholder Equity
Common Stock26,371
Accumulated Other Comprehensive Income 18,541
Other Stockholders Equity 3,745
Total Stockholder Equity (as reported)48,657
Total Stockholder Equity (calculated)48,657
+/-0
Other
Capital Stock26,371
Cash and Short Term Investments 5,001
Common Stock Shares Outstanding 13,321
Current Deferred Revenue638
Liabilities and Stockholders Equity 81,962
Net Debt -1,128
Net Invested Capital 52,530
Net Working Capital 23,454
Property Plant and Equipment Gross 12,234
Short Long Term Debt Total 3,873



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-30
> Total Assets 
0
70,871
0
0
84,191
79,210
83,321
73,931
85,120
84,252
76,192
76,445
78,917
71,252
71,588
73,808
68,181
68,111
74,816
73,487
78,729
76,273
73,758
83,352
84,049
83,330
96,170
85,672
92,981
95,030
95,753
97,681
90,553
79,269
82,110
87,469
92,509
100,333
94,046
89,435
95,818
81,962
81,96295,81889,43594,046100,33392,50987,46982,11079,26990,55397,68195,75395,03092,98185,67296,17083,33084,04983,35273,75876,27378,72973,48774,81668,11168,18173,80871,58871,25278,91776,44576,19284,25285,12073,93183,32179,21084,1910070,8710
   > Total Current Assets 
0
43,693
0
0
50,755
40,865
46,834
36,916
48,156
47,375
40,769
42,896
47,535
40,423
42,736
46,145
41,878
39,592
47,799
47,942
54,128
53,072
49,061
58,504
57,430
54,799
61,691
48,966
55,184
58,484
58,674
60,704
54,771
43,215
47,629
53,666
59,180
66,927
60,504
57,673
65,981
54,657
54,65765,98157,67360,50466,92759,18053,66647,62943,21554,77160,70458,67458,48455,18448,96661,69154,79957,43058,50449,06153,07254,12847,94247,79939,59241,87846,14542,73640,42347,53542,89640,76947,37548,15636,91646,83440,86550,7550043,6930
       Cash And Cash Equivalents 
0
360
0
0
627
385
1,076
769
5,520
7,207
2,740
3,608
6,024
5,150
7,391
12,080
11,128
4,450
4,532
5,564
10,230
7,811
2,084
6,738
9,162
2,204
9,693
3,683
6,520
8,583
5,865
10,660
5,299
4,832
811
5,081
5,855
9,660
4,750
5,829
3,713
5,001
5,0013,7135,8294,7509,6605,8555,0818114,8325,29910,6605,8658,5836,5203,6839,6932,2049,1626,7382,0847,81110,2305,5644,5324,45011,12812,0807,3915,1506,0243,6082,7407,2075,5207691,076385627003600
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,656
21,881
23,868
24,250
26,758
23,870
25,121
17,386
23,086
24,459
25,987
27,764
25,915
22,159
28,764
19,953
19,95328,76422,15925,91527,76425,98724,45923,08617,38625,12123,87026,75824,25023,86821,88123,65600000000000000000000000000
       Other Current Assets 
0
24,350
0
0
22,454
17,552
17,519
13,160
19,736
19,360
13,685
16,539
18,088
15,639
18,637
19,763
17,305
19,842
24,604
26,313
25,087
25,508
24,608
31,265
25,557
29,930
28,591
24,042
25,428
25,612
28,604
25,511
27,034
18,596
26,568
26,152
27,507
1,203
-1
3,648
1
1,676
1,67613,648-11,20327,50726,15226,56818,59627,03425,51128,60425,61225,42824,04228,59129,93025,55731,26524,60825,50825,08726,31324,60419,84217,30519,76318,63715,63918,08816,53913,68519,36019,73613,16017,51917,55222,4540024,3500
   > Long-term Assets 
0
27,178
0
0
33,436
38,345
36,486
37,014
36,963
36,877
35,424
33,549
31,382
30,829
28,852
27,663
26,302
28,519
27,017
25,544
24,601
23,201
23,794
24,847
26,619
28,530
34,479
36,705
37,797
36,546
37,079
36,977
35,782
36,054
34,481
33,802
33,329
33,407
33,542
31,762
29,837
27,305
27,30529,83731,76233,54233,40733,32933,80234,48136,05435,78236,97737,07936,54637,79736,70534,47928,53026,61924,84723,79423,20124,60125,54427,01728,51926,30227,66328,85230,82931,38233,54935,42436,87736,96337,01436,48638,34533,4360027,1780
       Property Plant Equipment 
0
1,746
0
0
2,044
1,925
1,824
1,642
1,500
1,084
936
824
697
649
413
381
332
506
459
441
395
351
343
472
227
742
1,465
1,435
1,397
1,359
1,321
1,780
1,815
1,892
1,826
1,724
1,657
1,639
1,576
1,514
1,452
1,390
1,3901,4521,5141,5761,6391,6571,7241,8261,8921,8151,7801,3211,3591,3971,4351,4657422274723433513954414595063323814136496978249361,0841,5001,6421,8241,9252,044001,7460
       Goodwill 
0
0
0
0
0
12,726
0
0
0
11,387
0
0
0
10,047
0
0
0
8,707
8,373
8,038
7,703
7,368
7,033
6,698
6,363
6,028
5,693
5,358
5,024
4,688
4,354
4,019
3,684
3,348
3,014
2,679
2,344
2,009
1,675
1,340
1,005
670
6701,0051,3401,6752,0092,3442,6793,0143,3483,6844,0194,3544,6885,0245,3585,6936,0286,3636,6987,0337,3687,7038,0388,3738,70700010,04700011,38700012,72600000
       Intangible Assets 
0
19,269
0
0
0
19,396
0
0
0
18,642
0
0
0
12,586
0
0
0
10,552
9,431
8,311
7,749
7,429
8,365
9,623
11,975
15,510
21,070
23,661
25,126
24,633
25,536
25,311
24,416
23,505
22,333
22,092
22,020
22,668
23,201
21,819
20,291
18,724
18,72420,29121,81923,20122,66822,02022,09222,33323,50524,41625,31125,53624,63325,12623,66121,07015,51011,9759,6238,3657,4297,7498,3119,43110,55200012,58600018,64200019,39600019,2690
       Other Assets 
0
0
0
0
0
0
72,973
74,029
73,927
0
0
0
0
0
0
0
52,605
0
0
51,089
0
0
48,491
49,695
0
57,061
5,774
73,411
31,376
30,498
31,404
31,178
30,283
30,813
6,830
1
29,328
-1
6,612
6,611
6,611
0
06,6116,6116,612-129,32816,83030,81330,28331,17831,40430,49831,37673,4115,77457,061049,69548,4910051,0890052,605000000073,92774,02972,973000000
> Total Liabilities 
0
58,352
0
0
75,308
37,482
43,320
38,879
52,382
34,335
32,930
38,727
42,380
33,904
33,203
28,044
27,500
27,277
35,755
33,775
39,128
37,239
34,378
41,551
40,201
38,144
48,060
33,201
38,675
45,499
44,913
42,807
39,028
35,231
39,457
44,220
48,564
54,458
50,395
45,743
50,145
33,305
33,30550,14545,74350,39554,45848,56444,22039,45735,23139,02842,80744,91345,49938,67533,20148,06038,14440,20141,55134,37837,23939,12833,77535,75527,27727,50028,04433,20333,90442,38038,72732,93034,33552,38238,87943,32037,48275,3080058,3520
   > Total Current Liabilities 
0
38,277
0
0
52,570
35,125
41,356
37,307
48,811
31,535
30,538
36,726
40,505
32,154
31,578
26,544
26,124
26,028
34,588
32,433
37,642
35,712
33,198
40,496
39,272
37,693
47,692
30,333
35,849
42,789
42,327
36,364
36,863
33,010
32,688
38,445
43,670
50,393
47,018
43,087
47,745
31,204
31,20447,74543,08747,01850,39343,67038,44532,68833,01036,86336,36442,32742,78935,84930,33347,69237,69339,27240,49633,19835,71237,64232,43334,58826,02826,12426,54431,57832,15440,50536,72630,53831,53548,81137,30741,35635,12552,5700038,2770
       Short-term Debt 
0
6,320
0
0
0
10,201
0
0
0
10,342
0
0
0
14,539
0
0
0
542
1,898
13,357
10,896
12,558
8,295
17,795
5,408
6,982
14,197
8,526
13,122
14,465
12,673
12,008
17,437
14,796
1,820
9,626
14,511
21,219
2,943
16,001
14,616
1,946
1,94614,61616,0012,94321,21914,5119,6261,82014,79617,43712,00812,67314,46513,1228,52614,1976,9825,40817,7958,29512,55810,89613,3571,89854200014,53900010,34200010,2010006,3200
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,526
13,122
14,465
12,673
12,008
17,437
14,796
1,820
9,626
14,511
21,219
2,943
16,001
14,616
1,946
1,94614,61616,0012,94321,21914,5119,6261,82014,79617,43712,00812,67314,46513,1228,526000000000000000000000000000
       Accounts payable 
0
15,452
0
0
0
14,108
0
0
0
13,577
0
0
0
10,558
0
0
0
11,285
15,814
11,060
20,682
17,079
16,868
14,672
18,778
17,995
23,398
11,512
14,408
18,357
21,184
19,713
15,153
12,242
13,545
21,845
20,537
23,138
23,257
15,749
23,500
21,436
21,43623,50015,74923,25723,13820,53721,84513,54512,24215,15319,71321,18418,35714,40811,51223,39817,99518,77814,67216,86817,07920,68211,06015,81411,28500010,55800013,57700014,10800015,4520
       Other Current Liabilities 
0
16,506
0
0
52,570
10,816
41,356
37,307
48,811
7,616
30,538
36,726
40,505
7,057
31,578
26,544
26,124
14,201
16,876
8,016
6,064
6,075
8,035
8,029
15,086
12,716
10,097
10,295
8,319
9,967
8,470
4,643
4,273
5,972
17,323
6,974
8,622
-12,847
7,746
1,090
913
7,184
7,1849131,0907,746-12,8478,6226,97417,3235,9724,2734,6438,4709,9678,31910,29510,09712,71615,0868,0298,0356,0756,0648,01616,87614,20126,12426,54431,5787,05740,50536,72630,5387,61648,81137,30741,35610,81652,5700016,5060
   > Long-term Liabilities 
0
20,075
0
0
22,738
2,357
1,964
1,572
3,571
2,800
2,392
2,001
1,875
1,750
1,625
1,500
1,376
1,249
1,167
1,342
1,486
1,527
1,180
1,055
929
451
368
2,868
2,826
2,710
2,586
6,443
2,165
2,221
6,769
5,775
4,894
4,065
3,377
2,656
2,400
2,101
2,1012,4002,6563,3774,0654,8945,7756,7692,2212,1656,4432,5862,7102,8262,8683684519291,0551,1801,5271,4861,3421,1671,2491,3761,5001,6251,7501,8752,0012,3922,8003,5711,5721,9642,35722,7380020,0750
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,667
2,542
2,417
6,275
1,996
1,814
6,199
5,446
4,637
3,873
3,184
2,482
2,225
0
02,2252,4823,1843,8734,6375,4466,1991,8141,9966,2752,4172,5422,6670000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
160
159
169
169
168
169
407
0
329
257
192
0
0
0
0
00001922573290407169168169169159160000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,661
25,126
24,632
25,536
25,311
24,416
23,505
0
22,092
22,020
22,669
0
0
0
0
000022,66922,02022,092023,50524,41625,31125,53624,63225,12623,661000000000000000000000000000
> Total Stockholder Equity
0
12,519
0
0
8,883
41,728
40,001
35,052
32,738
49,917
43,262
37,718
36,537
37,348
38,385
45,764
40,681
40,834
39,061
39,712
39,601
39,034
39,380
41,801
43,848
45,186
48,110
52,471
54,306
49,531
50,840
54,874
51,525
44,038
42,653
43,249
43,945
45,875
43,651
43,692
45,673
48,657
48,65745,67343,69243,65145,87543,94543,24942,65344,03851,52554,87450,84049,53154,30652,47148,11045,18643,84841,80139,38039,03439,60139,71239,06140,83440,68145,76438,38537,34836,53737,71843,26249,91732,73835,05240,00141,7288,8830012,5190
   Common Stock
0
8,429
0
0
0
14,227
0
0
0
20,691
0
0
0
20,691
0
0
0
25,289
25,289
25,289
25,289
25,289
25,289
25,289
25,289
25,289
25,289
25,560
25,624
25,624
25,624
26,104
26,104
26,104
26,104
26,104
26,104
26,371
26,371
26,371
26,371
26,371
26,37126,37126,37126,37126,37126,10426,10426,10426,10426,10426,10425,62425,62425,62425,56025,28925,28925,28925,28925,28925,28925,28925,28925,28925,28900020,69100020,69100014,2270008,4290
   Retained Earnings Total Equity000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,759
13,535
13,576
15,557
18,541
18,54115,55713,57613,53515,7590000000000000000000000000000000000000
   Capital Surplus 000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
-7,879
0
0
0
26,587
0
0
0
35,675
0
0
0
3,745
0
0
0
15,545
13,772
14,423
14,312
13,745
14,091
16,512
18,559
19,897
22,821
26,911
28,682
23,907
25,216
28,770
25,421
17,934
16,549
17,145
17,841
3,745
3,745
3,745
3,745
3,745
3,7453,7453,7453,7453,74517,84117,14516,54917,93425,42128,77025,21623,90728,68226,91122,82119,89718,55916,51214,09113,74514,31214,42313,77215,5450003,74500035,67500026,587000-7,8790



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue163,015
Cost of Revenue-151,944
Gross Profit11,07111,071
 
Operating Income (+$)
Gross Profit11,071
Operating Expense-3,521
Operating Income7,5507,550
 
Operating Expense (+$)
Research Development6,498
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense3,5216,498
 
Net Interest Income (+$)
Interest Income0
Interest Expense-1,392
Other Finance Cost-0
Net Interest Income-1,392
 
Pretax Income (+$)
Operating Income7,550
Net Interest Income-1,392
Other Non-Operating Income Expenses0
Income Before Tax (EBT)3,13311,967
EBIT - interestExpense = 6,158
3,133
3,956
Interest Expense1,392
Earnings Before Interest and Taxes (EBIT)7,5504,525
Earnings Before Interest and Taxes (EBITDA)9,139
 
After tax Income (+$)
Income Before Tax3,133
Tax Provision-570
Net Income From Continuing Ops2,5632,563
Net Income2,564
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses155,465
Total Other Income/Expenses Net-4,4171,392
 

Technical Analysis of Arcoma
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Arcoma. The general trend of Arcoma is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Arcoma's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Arcoma AB.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 14.15.

The bearish price targets are: 13.00 > 13.00 > 12.45.

Tweet this
Arcoma AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Arcoma AB. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Arcoma AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Arcoma AB. The current macd is 0.51907177.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Arcoma price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Arcoma. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Arcoma price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Arcoma AB Daily Moving Average Convergence/Divergence (MACD) ChartArcoma AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Arcoma AB. The current adx is 27.76.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Arcoma shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Arcoma AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Arcoma AB. The current sar is 12.48.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Arcoma AB Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Arcoma AB. The current rsi is 71.37. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Arcoma AB Daily Relative Strength Index (RSI) ChartArcoma AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Arcoma AB. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Arcoma price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Arcoma AB Daily Stochastic Oscillator ChartArcoma AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Arcoma AB. The current cci is 92.89.

Arcoma AB Daily Commodity Channel Index (CCI) ChartArcoma AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Arcoma AB. The current cmo is 51.84.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Arcoma AB Daily Chande Momentum Oscillator (CMO) ChartArcoma AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Arcoma AB. The current willr is -5.45454545.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Arcoma AB Daily Williams %R ChartArcoma AB Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Arcoma AB.

Arcoma AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Arcoma AB. The current atr is 0.5586226.

Arcoma AB Daily Average True Range (ATR) ChartArcoma AB Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Arcoma AB. The current obv is 1,589,093.

Arcoma AB Daily On-Balance Volume (OBV) ChartArcoma AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Arcoma AB. The current mfi is 77.60.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Arcoma AB Daily Money Flow Index (MFI) ChartArcoma AB Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Arcoma AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-31RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-03MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Arcoma AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Arcoma AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5071.375
Ma 20Greater thanMa 5012.608
Ma 50Greater thanMa 10012.274
Ma 100Greater thanMa 20010.762
OpenGreater thanClose13.700
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Arcoma with someone you think should read this too:
  • Are you bullish or bearish on Arcoma? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Arcoma? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Arcoma AB

I send you an email if I find something interesting about Arcoma AB.


Comments

How you think about this?

Leave a comment

Stay informed about Arcoma AB.

Receive notifications about Arcoma AB in your mailbox!